Clinical outcomes observation in stage IIB–IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy
Abstract Background To explore the feasibility of adjuvant surgery following concurrent chemoradiation therapy (CCRT) in stage IIB–IIIB (according to FIGO staging of 2009) cervical cancer and analyze risk factors of recurrence after surgery. Methods Forty-nine patients diagnosed with stage IIB–IIIB...
Main Authors: | Yong Li, Zhiying Chen, Xiang Wang, Xiumei Li, Jie Zhou, Yongchun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08146-3 |
Similar Items
-
Current Trends in Treating Cervical Cancer
by: Kung-Liahng Wang
Published: (2007-06-01) -
"STUDY OF CONCURRENT CISPLATIN AND EXTERNAL RADIOTHERAPY PRIOR TO RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN PATIENTS WITH STAGE IB-IIB CERVICAL CANCER"
by: M. Modares Gilani, et al.
Published: (2004-06-01) -
"STUDY OF CONCURRENT CISPLATIN AND EXTERNAL RADIOTHERAPY PRIOR TO RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN PATIENTS WITH STAGE IB-IIB CERVICAL CANCER"
by: M. Modares Gilani, et al.
Published: (2004-04-01) -
A comparative study on weekly versus three weekly cisplatin based concurrent chemoradiotherapy in treatment of carcinoma cervix; Patient compliance and Feasibility study
by: Dr. Pranabandhu Das, et al.
Published: (2019-09-01) -
The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
by: Alexandra D. Dreyfuss, et al.
Published: (2021-02-01)